| 1 |
25385188 | Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence. | 2015 May |
2 |
| 2 |
25661339 | ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy. | 2015 Feb |
1 |
| 3 |
25877445 | Reversible, time-dependent inhibition of CYP3A-mediated metabolism of midazolam and tacrolimus by telaprevir in human liver microsomes. | 2015 |
3 |
| 4 |
26158282 | Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir. | 2015 |
1 |
| 5 |
24332840 | Telaprevir is a substrate and moderate inhibitor of P-glycoprotein, a strong inductor of ABCG2, but not an activator of PXR in vitro. | 2014 Feb |
1 |
| 6 |
24369269 | Successful telaprevir treatment in combination of cyclosporine against recurrence of hepatitis C in the Japanese liver transplant patients. | 2014 |
2 |
| 7 |
22642697 | The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers. | 2013 Feb |
2 |
| 8 |
23137766 | Clinical management of drug-drug interactions in HCV therapy: challenges and solutions. | 2013 Apr |
1 |
| 9 |
23525057 | Telaprevir: changing the standard of care of chronic hepatitis C. | 2013 Jan-Mar |
1 |
| 10 |
23553423 | Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug-drug interactions. | 2013 Jul |
2 |
| 11 |
23703578 | Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors. | 2013 Oct |
3 |
| 12 |
23884060 | Drug-drug interactions in the treatment of HCV among people who inject drugs. | 2013 Aug |
1 |
| 13 |
24063896 | [Biochemical and pharmacological features of telaprevir]. | 2013 Jul |
1 |
| 14 |
24127648 | The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C. | 2013 Dec |
2 |
| 15 |
22162542 | Effect of telaprevir on the pharmacokinetics of midazolam and digoxin. | 2012 Oct |
1 |
| 16 |
22180548 | Telaprevir: an oral protease inhibitor for hepatitis C virus infection. | 2012 Jan 1 |
2 |
| 17 |
22951253 | Telaprevir: a hepatitis C NS3/4A protease inhibitor. | 2012 Sep |
1 |
| 18 |
23461440 | [Systematic review of new protease inhibitors interactions: telaprevir and boceprevir]. | 2012 Nov-Dec |
2 |
| 19 |
21825288 | Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin. | 2011 Oct |
2 |